Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 6/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28190576 | 0.98 | THRB (0.55) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL28189930 | 0.98 | THRB (0.55) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL12348212 | 0.94 | THRB (0.61) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL22698176 | 0.89 | TSHR (0.53) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL4087312 | 0.88 | TSHR (0.56) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL19884699 | 0.88 | TSHR (0.61) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL14395339 | 0.87 | THRB (0.45) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL23378084 | 0.86 | TSHR (0.65) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL20691517 | 0.85 | THRB (0.44) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL13793782 | 0.85 | THRB (0.44) | THRBTSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117777405-A | Ultraviolet light curing 3D printing resin and preparation method and application thereof | 浙江大学杭州国际科创中心 | 2024-03-29 | — | — | CN | claimed |
| US-8524816-B2 | curable protective coatings comprising a solids phase comprising polymer resins and blocked isocyanate, and degradation product neutralizing agents, having chemical and corrosion resistance, used as linings in diesel fuel tanks | MAGNI INDUSTRIES, INC. (US) | 2013-09-03 | — | — | US | claimed |
| US-20120080824-A1 | CAST POLYURETHANE AND POLYUREA COVERS FOR GOLF BALLS | ACUSHNET COMPANY (US) | 2012-04-05 | — | — | US | claimed |
| US-20080227897-A1 | COATING RESISTANT TO BIO-DIESEL FUELS | MAGNI INDUSTRIES, INC. (US) | 2008-09-18 | — | — | US | claimed |
| EP-1970395-A2 | Coating resistant to bio-diesel fuels | Magni Industries Inc. (US) | 2008-09-17 | — | — | EP | claimed |
| CN-117777405-A | Ultraviolet light curing 3D printing resin and preparation method and application thereof | 浙江大学杭州国际科创中心 | 2024-03-29 | — | — | CN | disclosed |
| CN-115043987-B | Composition for 3D printing, printing method and device | 珠海赛纳三维科技有限公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-115043987-A | Composition for 3D printing, printing method and device | 珠海赛纳三维科技有限公司 | 2022-09-13 | — | — | CN | disclosed |
| EP-3556816-B1 | AQUEOUS DISPERSION OF KETO- AND PHOSPHORUS ACID MONOMER-FUNCTIONALIZED POLYMER PARTICLES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-07-14 | — | — | EP | disclosed |
| CN-104250214-B | Polymerizable compounds and their use in liquid crystal displays | 默克专利股份有限公司 | 2018-10-19 | — | — | CN | disclosed |
| EP-3374357-A1 | DISUBSTITUTED DIARYLOXYBENZOHETERODIAZOLE COMPOUNDS | ENI S.p.A. (IT) | 2018-09-19 | — | — | EP | disclosed |
| US-10039864-B2 | Oligofluorinated cross-linked polymers and uses thereof | INTERFACE BIOLOGICS, INC. (CA) | 2018-08-07 | — | — | US | disclosed |
| US-20070134589-A1 | Positive resist composition and pattern forming method using the same | FUJIFILM CORPORATION (JP) | 2007-06-14 | — | — | US | disclosed |
| US-20070105045-A1 | Positive resist composition and pattern formation method using the positive resist composition | FUJIFILM CORPORATION | 2007-05-10 | — | — | US | disclosed |
| WO-2006110513-A1 | OPHTHALMIC DEVICES COMPRISING PHOTOCHROMIC MATERIALS HAVING EXTENDED PI-CONJUGATED SYSTEMS | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2006-10-19 | — | — | WO | disclosed |
| WO-2006110221-A1 | PHOTOCHROMIC MATERIALS HAVING EXTENDED PI-CONJUGATED SYSTEMS AND COMPOSITIONS AND ARTICLES INCLUDING THE SAME | TRANSITIONS OPTICAL, INC. (US) | 2006-10-19 | — | — | WO | disclosed |
| US-20060228557-A1 | Photochromic materials having extended pi-conjugated systems and compositions and articles including the same | TRANSITIONS OPTICAL, INC. | 2006-10-12 | — | — | US | disclosed |
| US-20060226402-A1 | Ophthalmic devices comprising photochromic materials having extended PI-conjugated systems | KIM BEON-KYU | 2006-10-12 | — | — | US | disclosed |
| EP-0580108-B1 | A photosensitive polyimide composition | ASAHI CHEMICAL IND (JP) | 1997-03-12 | — | — | EP | disclosed |
| EP-0376751-A1 | Polymerizable cyclic urea derivatives and polymers having a pendant urea | NIPPON PAINT CO., LTD. (JP) | 1990-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060228557-A1 | Photochromic materials having extended pi-conjugated systems and compositions and articles including the same | INCENP, PCNA, INTS6 | THRB 4882/4885TSHR 4793/4885ALDH1A1 2220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.